Atai Life Sciences Operating Expenses 2020-2024 | ATAI

Atai Life Sciences operating expenses from 2020 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Atai Life Sciences Annual Operating Expenses
(Millions of US $)
2023 $126
2022 $145
2021 $156
2020 $104
2019 $18
Atai Life Sciences Quarterly Operating Expenses
(Millions of US $)
2024-09-30 $23
2024-06-30 $26
2024-03-31 $24
2023-12-31 $34
2023-09-30 $27
2023-06-30 $32
2023-03-31 $33
2022-12-31 $38
2022-09-30 $38
2022-06-30 $36
2022-03-31 $33
2021-12-31 $45
2021-09-30 $34
2021-06-30 $61
2021-03-31 $16
2020-12-31 $87
2020-09-30 $7
2020-06-30 $6
2020-03-31 $4
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.200B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.704B 11.92
Quest Diagnostics (DGX) United States $16.912B 17.14
DaVita (DVA) United States $12.098B 15.65
Encompass Health (EHC) United States $9.453B 22.29
Chemed (CHE) United States $7.853B 24.14
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.284B 117.02
Option Care Health (OPCH) United States $3.848B 18.23
Amedisys (AMED) United States $2.744B 19.53
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
U.S Physical Therapy (USPH) United States $1.380B 36.27
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00